Reactive Carbonyls and Polyunsaturated Fatty Acids Produce a Hydroxyl Radical-like Species

The pattern of oxidized amino acids in aortic proteins of nonhuman primates suggests that a species resembling hydroxyl radical damages proteins when blood glucose levels are high. However, recent studies argue strongly against a generalized increase in diabetic oxidative stress, which might instead be confined to the vascular wall. Here, we describe a pathway for glucose-stimulated protein oxidation and provide evidence of its complicity in diabetic microvascular disease. Low density lipoprotein incubated with pathophysiological concentrations of glucose became selectively enriched in ortho-tyrosine and meta-tyrosine, implicating a hydroxyl radical-like species in protein damage. Model system studies demonstrated that the reaction pathway requires both a reactive carbonyl group and a polyunsaturated fatty acid, involves lipid peroxidation, and is blocked by the carbonyl scavenger aminoguanidine. To explore the physiological relevance of the pathway, we used mass spectrometry and high pressure liquid chromatography to quantify oxidation products in control and hyperglycemic rats. Hyperglycemia raised levels of ortho-tyrosine, meta-tyrosine, and oxygenated lipids in the retina, a tissue rich in polyunsaturated fatty acids. Rats that received aminoguanidine did not show this increase in protein and lipid oxidation. In contrast, rats with diet-induced hyperlipidemia in the absence of hyperglycemia failed to exhibit increased protein and lipid oxidation products in the retina. Our observations suggest that generation of a hydroxyl radical-like species by a carbonyl/polyunsaturated fatty acid pathway might promote localized oxidative stress in tissues vulnerable to diabetic damage. This raises the possibility that antioxidant therapies that specifically inhibit the pathway might delay the vascular complications of diabetes.

[1]  A. Chait,et al.  Hyperlipidemia in concert with hyperglycemia stimulates the proliferation of macrophages in atherosclerotic lesions: potential role of glucose-oxidized LDL. , 2004, Diabetes.

[2]  C. Scholfield,et al.  The role of lipids and protein kinase Cs in the pathogenesis of diabetic retinopathy , 2004, Diabetes/metabolism research and reviews.

[3]  S. Pennathur,et al.  Mechanisms of oxidative stress in diabetes: implications for the pathogenesis of vascular disease and antioxidant therapy. , 2004, Frontiers in bioscience : a journal and virtual library.

[4]  V. Monnier,et al.  Intervention against the Maillard reaction in vivo. , 2003, Archives of biochemistry and biophysics.

[5]  C. Kim,et al.  Enhanced vascular production of superoxide in OLETF rat after the onset of hyperglycemia. , 2003, Diabetes research and clinical practice.

[6]  R. Kowluru Effect of reinstitution of good glycemic control on retinal oxidative stress and nitrative stress in diabetic rats. , 2003, Diabetes.

[7]  J. Morrow Is oxidant stress a connection between obesity and atherosclerosis? , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[8]  G. Gao,et al.  Plasminogen kringle 5 reduces vascular leakage in the retina in rat models of oxygen-induced retinopathy and diabetes , 2003, Diabetologia.

[9]  S. Tannenbaum,et al.  Protein tyrosine nitration and peroxynitrite , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  Mark A. Smith,et al.  Diabetes‐induced nitrative stress in the retina, and correction by aminoguanidine , 2002, Journal of neurochemistry.

[11]  J. Keaney,et al.  Hyperglycemia increases endothelial superoxide that impairs smooth muscle cell Na+-K+-ATPase activity. , 2002, American journal of physiology. Cell physiology.

[12]  M. Brownlee Biochemistry and molecular cell biology of diabetic complications , 2001, Nature.

[13]  J. Skyler Microvascular complications. Retinopathy and nephropathy. , 2001, Endocrinology and metabolism clinics of North America.

[14]  L. Otvos,et al.  Phosphorylated osteopontin peptides suppress crystallization by inhibiting the growth of calcium oxalate crystals. , 2001, Kidney international.

[15]  C. Gerhardinger,et al.  Early cellular and molecular changes induced by diabetes in the retina , 2001, Diabetologia.

[16]  K. Litwak,et al.  A hydroxyl radical-like species oxidizes cynomolgus monkey artery wall proteins in early diabetic vascular disease. , 2001, The Journal of clinical investigation.

[17]  J. Keaney,et al.  Glucose enhancement of LDL oxidation is strictly metal ion dependent. , 2000, Free radical biology & medicine.

[18]  A. Carr,et al.  Oxidation of LDL by myeloperoxidase and reactive nitrogen species: reaction pathways and antioxidant protection. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[19]  Y. Kaneda,et al.  Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage , 2000, Nature.

[20]  A. Jenkins,et al.  Aminoguanidine and the effects of modified LDL on cultured retinal capillary cells. , 2000, Investigative ophthalmology & visual science.

[21]  S. Pennathur,et al.  Mass Spectrometric Quantification of 3-Nitrotyrosine, ortho-Tyrosine, and o,o′-Dityrosine in Brain Tissue of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated Mice, a Model of Oxidative Stress in Parkinson's Disease* , 1999, The Journal of Biological Chemistry.

[22]  J. Heinecke,et al.  Nitrogen dioxide radical generated by the myeloperoxidase‐hydrogen peroxide‐nitrite system promotes lipid peroxidation of low density lipoprotein , 1999, FEBS letters.

[23]  M. Obrenovich,et al.  Protein aging by carboxymethylation of lysines generates sites for divalent metal and redox active copper binding: relevance to diseases of glycoxidative stress. , 1999, Biochemical and biophysical research communications.

[24]  C van Ypersele de Strihou,et al.  Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications. , 1999, Kidney international.

[25]  J. Baynes,et al.  Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. , 1999, Diabetes.

[26]  David M Nathan,et al.  Some answers, more controversy, from UKPDS , 1998, The Lancet.

[27]  G. Lutty,et al.  Increased NADH oxidase activity in the retina of the BBZ/Wor diabetic rat. , 1998, Free radical biology & medicine.

[28]  T. Lyons,et al.  Age-dependent increase in ortho-tyrosine and methionine sulfoxide in human skin collagen is not accelerated in diabetes. Evidence against a generalized increase in oxidative stress in diabetes. , 1997, The Journal of clinical investigation.

[29]  E. Di Cera,et al.  Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. , 1997, Science.

[30]  C. Kilo,et al.  Cytosolic NADH/NAD+ , free radicals, and vascular dysfunction in early diabetes mellitus , 1997, Diabetologia.

[31]  K. Sharma,et al.  Biochemical events and cytokine interactions linking glucose metabolism to the development of diabetic nephropathy. , 1997, Seminars in nephrology.

[32]  C. Semenkovich,et al.  The Mystery of Diabetes and Atherosclerosis: Time for a New Plot , 1997, Diabetes.

[33]  F. Hsu,et al.  Mass Spectrometric Quantification of Markers for Protein Oxidation by Tyrosyl Radical, Copper, and Hydroxyl Radical in Low Density Lipoprotein Isolated from Human Atherosclerotic Plaques* , 1997, The Journal of Biological Chemistry.

[34]  S. Bursell,et al.  Amelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β Inhibitor , 1996, Science.

[35]  T. Lyons,et al.  The Advanced Glycation End Product, N-(Carboxymethyl)lysine, Is a Product of both Lipid Peroxidation and Glycoxidation Reactions (*) , 1996, The Journal of Biological Chemistry.

[36]  S. Hazen,et al.  p-Hydroxyphenylacetaldehyde Is the Major Product of L-Tyrosine Oxidation by Activated Human Phagocytes , 1996, The Journal of Biological Chemistry.

[37]  A. Pfeiffer,et al.  Diabetic microvascular complications and growth factors. , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[38]  J. Baynes,et al.  Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose. , 1995, Biochemistry.

[39]  M. Brownlee,et al.  Advanced protein glycosylation in diabetes and aging. , 1995, Annual review of medicine.

[40]  J. Heinecke,et al.  Tyrosyl radical generated by myeloperoxidase is a physiological catalyst for the initiation of lipid peroxidation in low density lipoprotein. , 1994, The Journal of biological chemistry.

[41]  A. Chait,et al.  Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide-dependent pathway. , 1994, The Journal of clinical investigation.

[42]  J. Baynes,et al.  Formation of o-tyrosine and dityrosine in proteins during radiolytic and metal-catalyzed oxidation. , 1993, The Journal of biological chemistry.

[43]  J. Nyengaard,et al.  Hyperglycemic Pseudohypoxia and Diabetic Complications , 1993, Diabetes.

[44]  D. Steinberg,et al.  Role of oxidized low density lipoprotein in atherogenesis. , 1991, The Journal of clinical investigation.

[45]  T. Lyons,et al.  Lipoprotein glycation and its metabolic consequences. , 1997, Diabetes.

[46]  T. Lyons,et al.  Accumulation of Maillard reaction products in skin collagen in diabetes and aging. , 1993, The Journal of clinical investigation.

[47]  V. Monnier,et al.  Pentosidine Formation in Skin Correlates With Severity of Complications in Individuals With Long-Standing IDDM , 1992, Diabetes.

[48]  M. Mcdaniel,et al.  Aminoguanidine, a Novel Inhibitor of Nitric Oxide Formation, Prevents Diabetic Vascular Dysfunction , 1992, Diabetes.

[49]  R. Bucala,et al.  Advanced glycosylation: chemistry, biology, and implications for diabetes and aging. , 1992, Advances in pharmacology.

[50]  S. Wolff,et al.  Protein glycation and oxidative stress in diabetes mellitus and ageing. , 1991, Free radical biology & medicine.

[51]  R. Dean,et al.  Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing. , 1988, The Biochemical journal.

[52]  S P Wolff,et al.  Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes. , 1987, The Biochemical journal.

[53]  J. Baynes,et al.  Effect of phosphate on the kinetics and specificity of glycation of protein. , 1987, The Journal of biological chemistry.

[54]  A. Chait,et al.  Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells. , 1986, The Journal of clinical investigation.

[55]  S. Fliesler,et al.  Chemistry and metabolism of lipids in the vertebrate retina. , 1983, Progress in lipid research.

[56]  S. Srinivasan,et al.  Effects of diabetes and high fat-high cholesterol diet on plasma lipid levels and on erythrocyte membrane composition. , 1982, Atherosclerosis.

[57]  N. Tolbert,et al.  A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. , 1978, Analytical biochemistry.

[58]  M. Aveldaño,et al.  High content of docosahexaenoate and of total diacylglycerol in retina. , 1972, Biochemical and biophysical research communications.